Prostate News Archive
02-Jan-2008
FDA flip-flop mobilizes prostate cancer patients to activism (Los Angeles Times)
After fast-tracking the end-stage cancer medication Provenge, the agency changed its mind. He'd been fighting prostate cancer for 12 years, and his doctor told him the disease was spreading, but Ted Girgus still had hope. Local writer offers Q & A on prostate treatments (The Nashua Telegraph)
"Will You (or Someone You Love) Get prostate Cancer?" ... Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer (EurekAlert!)
(PHILADELPHIA) Scientists at Jefferson?s Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. Jefferson Scientists Find Protein Potential Drug Target For Treatment-resistant Prostate Cancer (Medical News Today)
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. If the findings hold up, the protein, called Stat5, may be a specific drug target against an extremely difficult-to-treat cancer. [click link for full article]
Back to Prostate News Archive